Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
Desamfetamina
(+)-amphetamine
Dexanfetamina
(+)-¦Á-methylphenethylamine
Dexamphetamine
Dextroamphetamine adipate
(+)-(S)-amphetamine
(S)-1-phenyl-2-propylamine
Dextroamphetamine sulfate
d-amphetamine
(S)-(+)-¦Â-phenylisopropylamine
Dexamfetaminum
(S)-amphetamine
Dexamfetamina
(S)-¦Á-methylbenzeneethanamine
(S)-1-phenyl-2-aminopropane
Dextroamphetamine
Dexamfetamine
(+)-¦Á-methylphenylethylamine
(¦ÁS)-¦Á-methylbenzeneethanamine
(S)-(+)-amphetamine
Dextroamphetamine saccharate
Brand Names
Mydayis
Teva-dextroamphetamine SR
Dextroamphetamine Sulfate Extended-Release
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate
Dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate ER
Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Suflate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682